https://www.selleckchem.com/pr....oducts/cabotegravir-
001). Serum GOLPH3 concentrations in CRC patients correlated positively with CEA and CA19-9 concentrations ( 0.05). Serum GOLPH3 concentrations in GC and CRC patients are related to TNM stage. GOLPH3 may represent a novel biomarker for the diagnosis of GC and CRC. The combination of serum GOLPH3, CEA, and CA19-9 concentrations can improve diagnostic efficiency for GC and CRC. GOLPH3 is expected to become an indicator for the early diagnosis and evaluation of surgical effects. Serum GOLPH3 concentrations in GC
Like
Comment
Share
